Page 1 of 2
Loading...
Page 1 of 2
The global esoteric testing market size was valued at $20,218.60 million in 2020, and is estimated to reach $66,214.79 million by 2030, growing at a CAGR of 12.5% from 2021 to 2030.
The global single cell multiomics market size was valued at $2,458.80 million in 2020 and is projected to reach $13,908.30 million by 2030, registering a CAGR of 19.0% from 2021 to 2030.
The Malaysia nuclear medicine market was valued at $33.68 million in 2020, and is projected to reach $70.24 million by 2028, registering a CAGR of 9.86% from 2021 to 2028.
The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.
The global oncology drugs market was valued at $128,352 million in 2019, and is projected to reach $222,380 million by 2027, registering a CAGR of 7.4%.
The clinical trial imaging services market accounted for $1,310 million in 2019, and is expected to reach $1,807.65 million by 2027, registering a CAGR of 5.6% from 2020 to 2027.
The global cell separation technologies market size was valued at $8,639.20 million in 2019 and is projected to reach $28,766.14 million by 2027, registering a CAGR of 15.4% from 2020 to 2027.
Veterinary medicines are essential for animal health, as these are employed for treatment of various fatal diseases in animals such as cancer and seizures. Moreover, alarming increase in prevalence of various animal ...
The global epigenetics market was valued at $772 million in 2019, and is projected to reach $2,168 million by 2027, registering a CAGR of 13.6% from 2020 to 2027.
The Asia-Pacific oncology molecular diagnostics market was valued at $381.84 million in 2018 and is estimated to reach $732 million by 2026 growing at a CAGR of 9% for the forecast period of 2019–2026.
The global immuno-oncology assay market accounted for $2,769 million in 2018, and is expected to reach $ 6,179 million by 2026, growing at a CAGR of 10.6% from 2019 to 2026.
The global top 10 cancer drugs market sales was valued at $63,619 million in 2018 and is expected to reach $129,948 million by 2026, registering a CAGR of 9.8% from 2019 to 2026.
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 to 2026. Cancer is ...
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
The global endoscope + radiofrequency ablation (RFA) market was valued at $3,567 million in 2017 and is estimated to reach at $7,471 million by 2025, registering a CAGR of 9.6% from 2018 ...
3D medical imaging is a technique that creates visual representations of the interior body for medical analysis by utilizing 3D imaging modalities. 3D medical imaging enables the healthcare professionals to diagnose the ...
PET-CT Scanner Device Market accounted for $1,454 million in 2016, and is estimated to reach $2,108 million by 2023, growing at a CAGR of 5% during the analysis period (2017“2023). There is a high prevalence of diseases worldwide, hence an increase in the need of diagnosis.
The Precision Medicine Market was valued at $3,516 million in 2016, and is estimated to reach at $7,746 million by 2023, registering a CAGR of 11.9% from 2017 to 2023. Precision medicine ...
Global Molecular Diagnostics Market was valued at $5,962 million in 2016, and is expected to garner $10,557 million by 2023, registering a CAGR of 9.1% during the forecast period 2017-2023. Molecular diagnostic ...
Biosimilars or follow-on-biologics are highly similar versions of reference biologics derived from living organisms such as plants and animals. The development of biosimilars and validation with reference biologics play a significant role ...
Veterinary oncology is defined a medicine which deals with treatment of cancer in animals. The main reason of death of animals is cancer. Skin tumors are the most treated type of tumor ...
Superdisintegrants is the combination of substances which added to the drug formulation that facilitates the disintegration of tablet or capsule content into smaller particles. It consists of fragments of disintegrated parts of ...
Veterinary MRI is the system of imaging that is a common tool for the visualization of the nervous system. It is currently considered to be an ideal method for the imaging the ...
Biologics are genetically engineered proteins which are originated from genes of human. Biologic drugs target the specific parts of the human immune system. Biologics are completely different from chemically synthesized drugs. There ...
Biomaker is a measurable indicator of some biological state or condition. This biomarker is usually used in measurement and evaluation of blood, urine, and soft tissues. Biomakers are focusing on monitoring vital ...
Page 1 of 2
There might be something that we haven’t covered in the scope and if it is as per your specific areas of interest, we can anytime customise and incorporate your requirements in the framework of the study and provide you with a customised report based on your exact needs.